Esperto Medical: Series A Funding Raised For Delivering For Future Of Healthcare

By Amit Chowdhry • Feb 24, 2025

Esperto Medical, a health technology startup specializing in critical care and remote patient monitoring, announced the closing of an oversubscribed Series A investment round co-led by Catalyst Health Ventures and Bold Capital Partners, with support from Wavemaker Three-sixty Health, Free Flow Ventures, Fund@Caltech, and Maverick Ventures.

The funds will support the productization and clinical testing of Esperto’s new Resonance Sonomanometry (RSM) technology. RSM uses sound waves at different frequencies to measure blood pressure directly within arteries, avoiding the variability of other approaches. It requires no calibration, making it easy to set up and use. The details of the technique are published in PNAS Nexus.

KEY QUOTES:

“RSM’s flexibility to work all over the body – on the arms, legs, even the neck – allows it to accommodate a wide range of patients. It has the potential to enhance cardiovascular monitoring for everyone.”

– Cofounder and Chief Medical Officer, Alaina Rajagopal, MD, PhD

“RSM is a truly new monitoring technology and has significant competitive advantages. I am excited for its application not just in the hospital setting but in personal use, as well.”

– Joshua Phillips, co-founder and Managing Partner of Catalyst Health Ventures (joining the board)

“I have had the chance to track this technology from early days at Caltech. Esperto has built a great team to bring RSM to the clinic and beyond. I look forward to helping them continue their rapid progress toward transforming patient monitoring across hospital settings.”

– Helen McBride, PhD, Partner at Bold Capital Partners (joining the board)

“We are pleased to welcome CHV, Bold Capital Partners and others to Esperto as we work to advance RSM for the benefit of patients, providers, health care systems, and payors. We are thrilled to have the chance to bring forward a solution to a longstanding clinical problem: accurate, noninvasive, calibration-free, continuous blood pressure monitoring.”

– Aditya Rajagopal, PhD, co-founder and CEO of Esperto Medical